H. Pylori Eradication Using Pyklear in Adults in El Paso, Texas: a Pilot Study
Status:
Unknown status
Trial end date:
2011-08-01
Target enrollment:
Participant gender:
Summary
The proposed open-label one arm before-after clinical trial will assess the efficacy of a
14-day quadruple therapy containing 420mg of bismuth subcitrate potassium, 375mg of
metronidazole, 375mg of tetracycline hydrochloride (Pylera® packs from Axcan Pharma) and 20mg
of omeprazole in eradicating H. pylori infection in 50 asymptomatic adults in El Paso, Texas.
As part of the study we will obtain specimens for culture of H. pylori in a reference
laboratory.
Phase:
Phase 4
Details
Lead Sponsor:
The University of Texas Health Science Center, Houston